Works matching IS 10870156 AND DT 2011 AND VI 29 AND IP 7
Results: 36
A pipeline that integrates the discovery and verification of plasma protein biomarkers reveals candidate markers for cardiovascular disease.
- Published in:
- Nature Biotechnology, 2011, v. 29, n. 7, p. 635, doi. 10.1038/nbt.1899
- By:
- Publication type:
- Article
Teva hits bull's eye with Cephalon.
- Published in:
- Nature Biotechnology, 2011, v. 29, n. 7, p. 561, doi. 10.1038/nbt0711-561a
- By:
- Publication type:
- Article
French bioethics turmoil.
- Published in:
- Nature Biotechnology, 2011, v. 29, n. 7, p. 560, doi. 10.1038/nbt0711-560b
- By:
- Publication type:
- Article
RNA-Seq unleashed.
- Published in:
- Nature Biotechnology, 2011, v. 29, n. 7, p. 599, doi. 10.1038/nbt.1915
- By:
- Publication type:
- Article
In defense of life sciences venture investing.
- Published in:
- 2011
- By:
- Publication type:
- Opinion
Amgen's Brazilian buying spree.
- Published in:
- Nature Biotechnology, 2011, v. 29, n. 7, p. 561, doi. 10.1038/nbt0711-561b
- By:
- Publication type:
- Article
A targeted proteomics-based pipeline for verification of biomarkers in plasma.
- Published in:
- Nature Biotechnology, 2011, v. 29, n. 7, p. 625, doi. 10.1038/nbt.1900
- By:
- Publication type:
- Article
Optimer resurrects C. difficile antibiotic to win approval.
- Published in:
- Nature Biotechnology, 2011, v. 29, n. 7, p. 557, doi. 10.1038/nbt0711-557
- By:
- Publication type:
- Article
People.
- Published in:
- Nature Biotechnology, 2011, v. 29, n. 7, p. 668, doi. 10.1038/nbt.1920
- Publication type:
- Article
New Merck and Vertex drugs raise standard of care in hepatitis C.
- Published in:
- Nature Biotechnology, 2011, v. 29, n. 7, p. 553, doi. 10.1038/nbt0711-553
- By:
- Publication type:
- Article
Public biotech 2010-the numbers.
- Published in:
- Nature Biotechnology, 2011, v. 29, n. 7, p. 585, doi. 10.1038/nbt.1913
- By:
- Publication type:
- Article
Alkermes, Elan in $960 million merger.
- Published in:
- Nature Biotechnology, 2011, v. 29, n. 7, p. 559, doi. 10.1038/nbt0711-559b
- By:
- Publication type:
- Article
Biotechs follow big pharma lead back into academia.
- Published in:
- Nature Biotechnology, 2011, v. 29, n. 7, p. 555, doi. 10.1038/nbt0711-555
- By:
- Publication type:
- Article
Achieving better healthcare through diverse leadership.
- Published in:
- 2011
- By:
- Publication type:
- Interview
Avastin as good as Lucentis.
- Published in:
- Nature Biotechnology, 2011, v. 29, n. 7, p. 560, doi. 10.1038/nbt0711-560a
- By:
- Publication type:
- Article
Next-generation flow cytometry.
- Published in:
- Nature Biotechnology, 2011, v. 29, n. 7, p. 602, doi. 10.1038/nbt.1919
- By:
- Publication type:
- Article
Scant evidence supports EPA's pyramided Bt corn refuge size of 5%.
- Published in:
- Nature Biotechnology, 2011, v. 29, n. 7, p. 577, doi. 10.1038/nbt.1911
- By:
- Publication type:
- Article
Psoriasis: from bed to bench and back.
- Published in:
- Nature Biotechnology, 2011, v. 29, n. 7, p. 563, doi. 10.1038/nbt.1906
- By:
- Publication type:
- Article
Gates eyes biotechs as for-profit investments.
- Published in:
- Nature Biotechnology, 2011, v. 29, n. 7, p. 559, doi. 10.1038/nbt0711-559a
- By:
- Publication type:
- Article
In this issue.
- Published in:
- Nature Biotechnology, 2011, v. 29, n. 7, p. vii, doi. 10.1038/nbt.1923
- Publication type:
- Article
Members need only apply.
- Published in:
- 2011
- Publication type:
- Editorial
Selected reaction monitoring mass spectrometry reveals the dynamics of signaling through the GRB2 adaptor.
- Published in:
- Nature Biotechnology, 2011, v. 29, n. 7, p. 653, doi. 10.1038/nbt.1905
- By:
- Publication type:
- Article
New self-reporting for GM crops.
- Published in:
- Nature Biotechnology, 2011, v. 29, n. 7, p. 558, doi. 10.1038/nbt0711-558
- By:
- Publication type:
- Article
Biologic Indian detour adds value.
- Published in:
- Nature Biotechnology, 2011, v. 29, n. 7, p. 561, doi. 10.1038/nbt0711-561c
- By:
- Publication type:
- Article
Anti-galactose-?-1,3-galactose IgE from allergic patients does not bind ?-galactosylated glycans on intact therapeutic antibody Fc domains.
- Published in:
- Nature Biotechnology, 2011, v. 29, n. 7, p. 574, doi. 10.1038/nbt.1912
- By:
- Publication type:
- Article
Recent patent applications in sequencing and diagnostics.
- Published in:
- Nature Biotechnology, 2011, v. 29, n. 7, p. 598, doi. 10.1038/nbt.1921
- Publication type:
- Article
Mapping in vivo protein-RNA interactions at single-nucleotide resolution from HITS-CLIP data.
- Published in:
- Nature Biotechnology, 2011, v. 29, n. 7, p. 607, doi. 10.1038/nbt.1873
- By:
- Publication type:
- Article
Sequencing technology does not eliminate biological variability.
- Published in:
- Nature Biotechnology, 2011, v. 29, n. 7, p. 572, doi. 10.1038/nbt.1910
- By:
- Publication type:
- Article
Direct measurement of DNA affinity landscapes on a high-throughput sequencing instrument.
- Published in:
- Nature Biotechnology, 2011, v. 29, n. 7, p. 659, doi. 10.1038/nbt.1882
- By:
- Publication type:
- Article
Life sciences firms cheer unlocking of National Health Service.
- Published in:
- Nature Biotechnology, 2011, v. 29, n. 7, p. 560, doi. 10.1038/nbt0711-560c
- By:
- Publication type:
- Article
Streamlining biomarker discovery.
- Published in:
- Nature Biotechnology, 2011, v. 29, n. 7, p. 600, doi. 10.1038/nbt.1917
- By:
- Publication type:
- Article
Landscape of chromatin control element patents: positioning effects in pharmaceutical bioproduction.
- Published in:
- Nature Biotechnology, 2011, v. 29, n. 7, p. 593, doi. 10.1038/nbt.1907
- By:
- Publication type:
- Article
Research highlights.
- Published in:
- Nature Biotechnology, 2011, v. 29, n. 7, p. 605, doi. 10.1038/nbt.1924
- Publication type:
- Article
Therapeutic targeting of the IL-12/23 pathways: generation and characterization of ustekinumab.
- Published in:
- Nature Biotechnology, 2011, v. 29, n. 7, p. 615, doi. 10.1038/nbt.1903
- By:
- Publication type:
- Article
Full-length transcriptome assembly from RNA-Seq data without a reference genome.
- Published in:
- Nature Biotechnology, 2011, v. 29, n. 7, p. 644, doi. 10.1038/nbt.1883
- By:
- Publication type:
- Article
Industry access to the literature.
- Published in:
- Nature Biotechnology, 2011, v. 29, n. 7, p. 571, doi. 10.1038/nbt.1909
- By:
- Publication type:
- Article